Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 204

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Neurodevelopmental Outcomes of Premature Infants Treated with Inhaled Nitric Oxide

Open access
Mestan, Karen K.L., Marks, Jeremy D., Hecox, Kurt, Huo, Dezheng, Schreiber, Michael D. · 2005 · New England Journal of Medicine

Abstract

BACKGROUND: Chronic lung disease and severe intraventricular hemorrhage or periventricular leukomalacia in premature infants are associated with abnormal neurodevelopmental outcomes. In a previous randomized, controlled, single-center trial of premature infants with the respiratory distress syndrome, inhaled nitric oxide decreased the risk of death or chronic lung disease as well as severe intraventricular hemorrhage and periventricular leukomalacia. We hypothesized that infants treated with inhaled nitric oxide would also have improved neurodevelopmental outcomes. METHODS: We conducted a prospective, longitudinal follow-up study of premature infants who had received inhaled nitric oxide or placebo to investigate neurodevelopmental outcomes at two years of corrected age. Neurologic examination, neurodevelopmental assessment, and anthropometric measurements were made by examiners who were unaware of the children's original treatment assignment. RESULTS: A total of 138 children (82 percent of survivors) were evaluated. In the group given inhaled nitric oxide, 17 of 70 children (24 percent) had abnormal neurodevelopmental outcomes, defined as either disability (cerebral palsy, bilateral blindness, or bilateral hearing loss) or delay (no disability, but one score of less than 70 on the Bayley Scales of Infant Development II), as compared with 31 of 68 children (46 percent) in the placebo group (relative risk, 0.53; 95 percent confidence interval, 0.33 to 0.87; P=0.01). This effect persisted after adjustment for birth weight and sex, as well as for the presence or absence of chronic lung disease and severe intraventricular hemorrhage or periventricular leukomalacia. The improvement in neurodevelopmental outcome in the group given inhaled nitric oxide was primarily due to a 47 percent decrease in the risk of cognitive impairment (defined by a score of less than 70 on the Bayley Mental Developmental Index) (P=0.03). CONCLUSIONS: Premature infants treated with inhaled nitric oxide have improved neurodevelopmental outcomes at two years of age.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa043514

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. 10.1016/S0002-9378(98)70037-7 · DOI · Paper page
  2. 10.1111/j.1651-2227.1994.tb13005.x · doi:10.1111/j.1651-2227.1994.tb13005.x
  3. 10.1016/S0378-3782(98)00052-8 · DOI · Paper page
  4. 10.1056/NEJMoa032089 · DOI · Paper page
  5. 10.1542/peds.105.6.1216 · DOI · Paper page
  6. 10.1056/NEJMoa031154 · DOI · Paper page
  7. 10.1016/S0022-3476(98)70142-8 · doi:10.1016/s0022-3476(98)70142-8
  8. Swaiman KF, Russman BS. Cerebral palsy. In: Swaiman KF, Ashwal S, eds. Pediatric neurology: principles and practice. 3rd ed. St. Louis: Mosby, 1999:314.
  9. Hack M, 2000, Arch Pediatr Adolesc Med, 154, 725, 10.1001/archpedi.154.7.725 · DOI · Paper page
  10. 10.1093/aje/kwh090 · DOI · Paper page
  11. 10.1016/S0022-3476(78)80282-0 · DOI · Paper page
  12. 10.1542/peds.107.1.e1 · DOI · Paper page
  13. 10.1111/j.1365-3016.1998.00081.x · DOI
  14. Pinto-Martin JA, 1995, Pediatrics, 95, 249, 10.1542/peds.95.2.249 · DOI · Paper page
  15. 10.1016/S0095-5108(05)70027-0 · DOI
  16. 10.1542/peds.100.4.633 · DOI · Paper page
  17. 10.1037/0012-1649.15.2.225 · doi:10.1037/0012-1649.15.2.225
  18. 10.1136/fn.85.3.F159 · DOI
  19. 10.1038/380221a0 · DOI · Paper page
  20. 10.1097/00004647-199903000-00011 · DOI · Paper page
  21. 10.1016/S0361-9230(02)00808-0 · doi:10.1016/s0361-9230(02)00808-0
  22. 10.1016/j.jchemneu.2003.08.004 · doi:10.1016/j.jchemneu.2003.08.004
  23. 10.1016/j.niox.2004.04.001 · DOI
  24. 10.1056/NEJMc052087 · doi:10.1056/nejmc052087

Cited by

See all 204

Metadata

Authors
Mestan, K. K. L., Marks, J. D., Hecox, K., Huo, D., & Schreiber, M. D.
Venue
New England Journal of Medicine
Published
2005-07-07
Volume
353
Issue
1
Pages
23-32
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2065389442
Cited by
204
References
3
FWCI
22.20
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.